Morning Overview on MSN

A daily multivitamin slowed all five epigenetic aging clocks in a randomized trial — people who started biologically older benefited most

Among nearly 1,000 older adults randomly assigned to take either a daily multivitamin or a placebo for two years, those in ...

Tiger BioSciences Announces Publication of Interim TIGERCAMP Randomized Controlled Trial Data Demonstrating caregraFT™ Plus Standard of Care Outperform…

Tiger BioSciences announced the publication of interim data from the ongoing TIGERCAMP randomized controlled trial (RCT), now ...

Artios Announces First Patient Dosed in Randomized Phase 2 POLKA Study Evaluating DNA Polymerase Theta Inhibitor ART6043 in gBRCA-mutated HER2-Negative Breast Cancer

Key milestone positions ART6043 as the most advanced Pol-theta inhibitor in clinical development; the potentially first-in-class program is ...
Medical Dialogues

A randomised trial comparing imaging-guided PCI with Orsiro vs Xience

Previous clinical trials suggested that ultra-thin strut biodegradable polymer sirolimus-eluting stent (BP-SES) may be ...

MiNK Therapeutics Announces First Patient Dosed in Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury and Critical Illness

First patient dosed marks rapid transition from trial activation to active treatment in patients with acute lung injury from ...
ascopubs.org

Phase II Dose-Randomized Study of Sunvozertinib in Platinum-Pretreated Non–Small Cell Lung Cancer With Epidermal Growth Factor Receptor Exon 20 Insertion Mutations (WU-KONG1B)

Impact of Human Epidermal Growth Factor Receptor 2 in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab or Anti-EGFRs: Exploratory Analysis of Eight Randomized ...
ascopubs.org

A phase 2 randomized study comparing telisotuzumab adizutecan monotherapy with standard of care in patients with post-adjuvant circulating tumor DNA-positive colorectal cancer.

A phase 1b/2, multicenter, open-label study to evaluate the efficacy and safety of GSK5764227 (GSK’227), alone and in combination in patients with previously treated advanced unresectable or ...